The Regulation of Mammary Cell Growth: Determining the Role of Clock by Erickson, Emily C.
T H E  R E G U L A T I O N  O F  
    M A M M A R Y  C E L L  G R O W T H
Abstract
Changes in modern lifestyle such as lack of sleep, stress, and 
light exposure late at night are associated with increased rates 
of breast cancer. Most physiological processes, including 
growth, development, and metabolism, are controlled by 
circadian clocks. Circadian clocks respond to environmental 
cues to synchronize internal physiological processes, and 
thus, the disruption of this system may be responsible for 
this connection. The master clock in the brain coordinates 
peripheral circadian clocks located in every tissue of the 
body, including the mammary gland, and the core circadian 
component CLOCK regulates circadian oscillation of gene 
expression. Currently, the physiological function of the 
mammary clock, and the role of CLOCK in mammary cell 
growth and differentiation, are unknown. Our objective was to 
determine if the molecular clock controls mammary epithelial 
cell growth. shRNA specific for Clock was transfected into a 
normal mouse mammary epithelial cell line, HC-11. Q-PCR 
and western blot analysis showed shClock transfection 
significantly reduced Clock mRNA and protein abundance. 
Temporal analysis of molecular clock gene Per1 showed loss of 
circadian oscillation in shClock transfected cells, indicating loss 
of molecular clock function. Cyclin D1 (Ccnd1) expression was 
elevated in shClock transfected cells, and growth curve analysis 
revealed that shClock transfected cells had significantly shorter 
doubling time than HC-11 control cells. These findings support 
that CLOCK regulates mammary epithelial cell growth and 
suggests that disruption of circadian clock mechanisms may 
lead to cancer by altering cell growth regulation. 
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T H E  R E G U L A T I O N  O F  M A M M A R Y  C E L L  G R O W T H : 
Determining the Role of Clock 
INTRODUCTION
As the world continues to progress in medicine and health, 
cancer remains one of the diseases that society has yet to 
develop successful treatments and preventative measures 
against. In the United States, the most common form of 
cancer in women is breast cancer, which accounts for 
over 14% of all new cancer cases each year (National 
Cancer Institute, 2014). Interestingly, the incidence of 
breast cancer has dramatically increased in industrialized 
nations (Stevens, 2009). Changes in lifestyle due to 
industrialization, such as lack of sleep, stress, and light 
exposure late at night, may play a role in the increase 
in cancer incidence (Stevens, 2009). The human body 
possesses a circadian system to link external cues, for 
example, a light-dark cycle that results from the rotation 
of the Earth every 24 hours, with internal physiological 
processes. Changes in lifestyle, such as shift work and 
jetlag, which are inconsistent with external cues familiar 
to humans, disrupt the circadian system (Albrecht & 
Eichele, 2003). Shift work involving a circadian disruption 
was recently classified as “probably carcinogenic” by 
the International Agency for Research on Cancer (Bonde 
et al., 2012). A better understanding of the mechanisms 
governing molecular clocks and how they regulate 
physiology may lead to the discovery of links between 
circadian disruptions and cancer. The research reported 
herein investigates the role of a core circadian clock gene, 
Clock, in regulation of mammary epithelial cell growth. 
Circadian rhythms are 24-hour (h) cycles in behavior and 
physiology (e.g., sleep-wake cycles, plasma hormone 
levels, and body temperature) that evolved to coordinate 
an organism’s internal physiological processes with its 
external environment (Albrecht & Eichele, 2003). The 
master circadian clock is located in the suprachiasmatic 
nuclei (SCN) of the brain and functions to coordinate the 
timing of peripheral circadian clocks located in every 
tissue of the body (Bonde et al., 2012). One of the primary 
environmental cues the master clock responds to is light-
dark cycles. The master clock translates photoperiod 
signals into neural and hormonal cues that serve as inputs 
to clocks in peripheral tissues (Dahl, Tao, & Thompson, 
2012). Molecular clocks within each tissue generate 
circadian rhythms of gene expression, which then translate 
into physiological and metabolic rhythms. 
Figure 1. Mechanism of circadian rhythm generation by 
molecular clocks. See text for details.
At the molecular level, circadian rhythms are generated 
through a transcription-translation feedback loop composed 
of a set of core clock genes. Circadian locomotor output 
cycles kaput (Clock) and aryl hydrocarbon receptor nuclear 
translocator-like (Arntl) are among the core clock genes. 
As seen in Figure 1, CLOCK and ARNTL proteins come 
together to form a transcription factor that binds to an 
E-box sequence. E-box sequences are nucleotide sequences 
in the promoter region of a gene that transcription factors 
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bind to in order to regulate expression of the gene. The 
CLOCK:ARNTL transcription factor binds to the E-box 
sequence in the promoter region of the core clock genes 
Period (Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2) 
and initiates their transcription. Together, PER and CRY 
proteins inhibit the formation of the CLOCK:ARNTL 
dimer, thus repressing their own transcription. Besides 
regulating Per and Cry genes, the CLOCK:ARNTL 
transcription factor also has the potential to bind E-box 
sequences in the promoter region of other genes (i.e., 
clock-controlled genes), resulting in circadian oscillation 
in 5–10% of genes expressed in every tissue of the body 
(Casey & Plaut, 2012). 
Nearly all physiological systems in the body are regulated 
by circadian clocks, including the regulation of cell 
growth. Cell cycle progression occurs at specific times 
of the day and night, and in many organs, the Gap1/
Synthesis (G1/S) checkpoint of the cell cycle is expressed 
rhythmically, suggesting that the circadian system may 
play a role in its regulation (Fu, Patel, Bradley, Wagner, & 
Karsenty, 2005). In support of circadian clock regulation 
of cell growth is the finding that cyclin D1 (Ccnd1), 
which regulates progression of the cell cycle at the G1/S 
transition, is elevated in Period1 and Period2 knockout 
mice (Per1-/- and Per2m/m, respectively). Osteoblasts 
from Per1-/- and Per2m/m mice had shorter cell cycles 
and increased rate of cell growth (Fu et al., 2005). This 
supports the idea that the cell cycle is controlled in part by 
components of the circadian clock through regulation of 
Ccnd1 and likely other factors (Matsuo et al., 2003). 
A common method for determining the function of a 
gene is to reduce the expression of that gene. This can 
be done by transfecting short hairpin RNA (shRNA) into 
cells. Transfection is the process of introducing nucleic 
acids, such as shRNA, into a eukaryotic cell. The shRNA 
is a sequence of RNA that is complementary to the 
target gene of interest (Rao, Vorhies, & Senzer, 2009). 
Once transfected into the cell, shRNA integrates into the 
genome and begins to transcribe the shRNA product. The 
shRNA product is processed by cellular machinery (Dicer 
and the RNA-induced silencing complex [RISC]) to 
produce an activated RISC that contains a single strand of 
small interfering RNA (siRNA). siRNAs target and cleave 
complementary mRNA, which decreases the expression 
of the target gene (Rao et al., 2009). To study circadian 
clock regulation of mammary growth, shRNA specific for 
the mouse gene Clock, shClock, was transfected into a 
mouse mammary epithelial cell line, HC-11. The goals of 
this study were: (a) to reduce Clock expression in HC-11 
cells by transfecting shClock into cultures; (b) to measure 
the effect of shClock on CLOCK protein abundance; and 
(c) to determine whether shClock impacts growth of cells 
using growth curve analysis.
EXPERIMENTAL PROCEDURES
HC-11 Cell Culture Maintenance and Passaging
HC-11 cells were cultured in complete growth medium 
(RPMI 1640 supplemented with 2g/L sodium bicarbonate, 
100 U/mL penicillin, 100 µg/mL streptomycin, 10% heat 
inactivated calf serum, 5 µg/mL insulin, and 10 ng/mL 
epidermal growth factor [EGF]) in 5% CO2 at 37°C. Cell 
culture media was changed every two days. Cells were 
rinsed once with sterile phosphate buffered saline (PBS) 
prior to media change. Cells were passaged, or split, when 
they reached 80% confluence (i.e., when cells filled 80% 
of the bottom of the culture dish). Cells were passaged 1:3 
for maintenance by incubation in 0.25% Trypsin EDTA. 
shRNA Transfection and  
Selection of Dilutional Clones
Four unique Qiagen SureSilencing shRNA plasmid 
sequences specific to the mouse Clock gene (Table 1) 
were transfected into HC-11 cells. Each shRNA plasmid 
carried a U1 promoter, an shRNA sequence, and a gene for 
hygromycin resistance. 
Plasmids were introduced into E. cloni chemically 
competent bacterial cells, which were used to amplify 
the quantity of plasmid for future use in transfections. 
The plasmid was then isolated from the bacterial cells 
following Qiagen’s instructions for the Endofree Plasmid 
Maxi kit. Next, the plasmids were linearized by restriction 
digest using the enzyme BsaI-HF and kit (New England 
BioLabs, Inc.). 
A hygromycin dose response curve was used to determine 
the lethal dose of hygromycin for nontransfected cells 
(concentration needed to kill 100% of nonresistant cells). 
Cells were grown to confluence and then wells were treated 
in duplicate with varying concentrations of hygromycin 
(100, 200, 400, 600, 800, and 1,000 µg/mL). Media was 
changed every 48 hours, and wells were monitored for 
signs of cell death starting on day 7. The lethal dose of 
hygromycin was determined to be 200 µg/mL. 
For transfection, HC-11 cells were plated at a density 
of 100,000 cells/mL in 24-well cell culture plates with 
Table 1. Identification of Plasmid Sequences.






4     journal of purdue undergraduate research: volume 4, fall 2014
complete growth media. Linearized Clock shRNA 
plasmids were transfected into HC-11 cells using the 
lipofection transfection reagent Attractene (Qiagen cat. 
no. 1051561). Transfections were optimized by varying 
timing of exposure to transfection complexes following 
the manufacturer’s protocol. Transfection complexes (0.3 
µg linearized DNA, Optimem I Reduced Serum Media 
[Life Technologies] to a total of 25 µl, and 1.13 µl of the 
Attractene Transfection Reagent) were added to each well. 
Transfection was performed in duplicate for each plasmid 
sequence. 
After transfected cells reached confluence, hygromycin 
was added at the lethal concentration for nontransfected 
cells (200 µg/mL). As a result, cells viable after 7 days of 
hygromycin selection contained the plasmid. To ensure 
continued selection of cells carrying plasmids, media was 
supplemented with maintenance strength of hygromycin 
(50 µg/mL). 
The effect of plasmid transfection on the level of Clock 
mRNA expression was screened using RT-qPCR. Based 
on lowest levels of Clock mRNA expression, two lines 
of HC-11 cells were selected for further experimentation. 
These lines carried Sequence 2 and Sequence 4 plasmids. 
Nontransfected HC-11 cells served as wild-type control. 
To achieve a more consistent level of Clock mRNA 
expression, and to increase experimental repeatability, 
one cell from each plasmid sequence was isolated and 
grown into a clonal population using dilutional cloning, a 
process of serial dilutions used to obtain a cell culture well 
containing only one cell, which can then be grown into a 
population of clonal cells. 
RNA Isolation and Real-Time Quantitative  
PCR Analysis (RT-qPCR)
Transfected cells and wild-type HC-11 cells were plated in 
duplicate wells at 100,000 cells/well in 35mm2 dishes in 
complete growth media. Molecular circadian clocks were 
then synchronized by media change once cells reached 
confluence. RNA was isolated from cultures 4 hours and 
16 hours after synchronization. Previous studies showed 
that these time points were equivalent to peak and trough 
levels of core clock gene expression (Casey et al., 2014). 
RNA was collected from cells and isolated using Qiagen’s 
RNeasy kit, and it was evaluated for quality using the 
Nanochip (Agilent, Inc.’s Bioanalyzer 2100) and quantity 
using Nanodrop. 
Gene expression was analyzed using TaqMan One-Step 
RT-qPCR (Life Technologies). Mouse-specific gene 
expression assays were used to measure the expression 
of Clock (cat. no. Mm00455950_m1), Per1 (cat. no. 
Mm00501813_m1), Ccnd1 (cat. no. Mm00432359_ m1), 
and β-actin (cat. no. Mm00607939_s1) in lines carrying 
shRNA insert Sequences 2 and 4, relative to the 
expression in nontransfected HC-11 controls. 
Knock-down (Kd), or reduction of Clock expression, was 
calculated using Equation 1. 
Equation 1.
ClockKD = 100 * (1 – 2
∆∆CT)
where  ∆∆CT = ∆CTsample – ∆CTnegative control 
  ∆CTsample = CTsample – CTreference
Note: “Negative control” designates nontransfected HC-11 
cultures.
In RT-qPCR, the cycle threshold (CT) is the cycle number 
in which the gene of interest exceeds the threshold 
value, and it is used to calculate relative gene expression 
(Applied Biosystems, 2008). Relative expression (RQ) 
of Clock, Per1, and Ccnd1 were calculated with β-actin 
as the reference gene, using the delta-delta CT method. 
Expression was normalized to the average expression 
in wild-type HC-11 cells across 4-hour and 16-hour 
time points. Data are presented as log base 2 of relative 
expression levels. 
Protein Isolation and Western Blot Analysis
Protein was harvested to determine the effect of shClock 
on abundance of CLOCK protein. Duplicate wells of 
each clonal line were plated at 700,000 cells per 100 cm2 
cell dish and grown to confluence. Protein lysates were 
isolated from cultures by pouring off media, washing 
cells two times with chilled PBS, and adding 500 µl of 
NP40 Protein Extraction Buffer (150 mM NaCl, 1.0% 
Nonidet-P40, 50 mM Tris-HCl pH 8.0, and protease 
inhibitors) to each dish. Cell lysates were then harvested 
using a chilled scraper and transferred to a 1.5 mL 
microfuge tube. To further aid cell lysis so that proteins 
could be isolated, the suspension was drawn up and 
expelled through a 26.5 gauge 1 ml syringe. Tubes were 
then shaken for 30 minutes on a VWR Mini Vortexer, 
followed by centrifugation for 20 minutes at 16,000 g at 
4°C. Protein was then aliquotted into microfuge tubes and 
stored at -80°C until further use. Protein concentration 
was measured using the Quick Start Bradford Protein 
Assay (Biorad). 
Fifteen µg of protein was loaded per lane and 
electrophoresed on a 10% TGX precast SDS PAGE gel 
from BioRad. The protein was then transferred onto a 
Polyvinylidene fluoride (PVDF) membrane for western 
blot analysis. Membranes were probed for CLOCK 
and B-ACTIN proteins using Anti-CLOCK (AbCam, 
ab3517) and Anti-B-ACTIN (AbCam ab8227) antibodies 
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Data and Statistical Analysis
Data are presented as mean ± standard error (SE). A 
statistical analysis was performed using Minitab software. A 
student t-test was used to analyze whether shRNA sequences 
significantly impacted variables (relative expression, protein 
abundance, doubling time, and cell density) relative to 
wild-type HC-11 cultures. General linear model was used to 
determine the effect of treatment and time on cell number. 
A Tukey’s test was used for post hoc pairwise comparisons. 
Significance was considered P ≤ 0.05.
RESULTS
RT-qPCR analysis of HC-11 cells transfected with shClock 
Sequence 2 and Sequence 4 revealed a ~70% and ~30% 
reduction in Clock mRNA expression, respectively, 
relative to wild-type HC-11 control cells. Western blot 
analysis was used to determine if decrease in Clock 
mRNA levels affected CLOCK protein abundance. 
Analysis of western blot band intensity showed a 20% 
and 9% reduction in CLOCK to B-ACTIN ratio relative 
to wild-type HC-11 cultures (Figure 2). A student t-test 
comparing wild-type HC-11 and Sequence 2 and Sequence 
4 transfected cell lines showed that CLOCK/B-ACTIN 
ratio was significantly less in Sequence 2 transfected cells, 
and thus support that CLOCK protein abundance was 
lower in cultures carrying Sequence 2 shClock. However, 
the CLOCK protein abundance was not significantly 
different (P > 0.05) between wild-type HC-11 cultures and 
Sequence 4 transfected cells.
RT-qPCR analysis was used to determine the effect of 
shRNA sequences on expression of Clock, Per1, and 
at dilutions of 1/5,000 and 1/7,500, respectively. The 
secondary antibody (ab97051) was then incubated on the 
blots at the dilution of 1/100,000. Membranes were washed 
with the detection reagent ECL Plus substrate solution (GE 
Healthcare). Blots were imaged using the Typhoon imaging 
system, and the relative band intensity was measured. 
Growth Curve Analysis
A growth curve analysis was used to determine if CLOCK 
affects HC-11 cell growth characteristics. Wild-type 
HC-11 cells, and Sequence 2 and Sequence 4 transfected 
cells were plated in duplicate wells at 100,000 cells/
well in 35mm2 dishes in normal growth media. Duplicate 
wells were counted on days 2, 4, 6, and 8, with media 
changed every 2 days. Cells were trypsinized, pelleted by 
centrifugation, and resuspended in sterile PBS. Trypan 
blue (0.4%, Sigma-Aldrich) was added in a 1:1 ratio 
to the cell suspension for live-dead staining. Each well 
was counted twice for live cells using a BioRad TC20 
cell counter. Mean values of the technical and biological 
replicates and standard deviation of cell counts were 
graphed. The doubling times of cells during exponential 
growth were calculated using Equation 2: 
Equation 2.
Doubling Time = T * ln2
                                Xe
                                Xb
Where T is the incubation time in any units, Xb is the cell 
number at the beginning of the incubation, and Xe is the 
cell number at the end of the incubation time. Growth 
curve experiments were repeated three times. 
Figure 2. Western blot analysis of the impact of shRNA sequence on CLOCK protein abundance. Western blot analysis of CLOCK 
expression in wild-type HC-11 (lanes 2 and 3) cells, and HC-11 cells transfected with Sequence 2 (lanes 4 and 5) or 4 (lanes 6 
and 7) shClock, and protein ladder in lane 1 (A). Total protein was collected after cells had been grown to confluence. Protein was 
electrophoresed on an SDS PAGE gel and then transferred to a PVFD membrane for western blotting. Membranes were probed using 
anti-CLOCK and anti-B-ACTIN, followed by incubation with secondary antibody, which was visualized by incubating with ECL-Plus. 
Blots were imaged using the Typhoon imaging system, and the relative band intensity was measured. CLOCK:B-ACTIN ratios are 
reported from wild-type HC-11 (black bar) and HC-11 transfected with Sequence 2 (gray bar) or Sequence 4 (white bar) (B). Values are 
mean ration ± SE; *indicates a difference at P < 0.05.
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Ccnd1 genes at 12-hour intervals after synchronization 
(Figure 3). At both 4 hours and 16 hours, Clock expression 
was decreased in cultures transfected with Sequence 
2 shRNA relative to wild-type HC-11 cultures. Per1 
expression showed a large change in expression in HC-11 
cells between 4-hour and 16-hour time points, oscillating 
in relative expression from 0.77 ± 0.20 to -0.77 ± 0.62. 
There was little to no change in Per1 expression levels 
between 4 hours and 16 hours in Sequence 2 transfected 
cells, varying from -0.11 ± 0.23 to 0.11 ± 0.04. In lines 
carrying Sequence 4, shClock relative expression of Per1 
varied from 0.34 ± 0.070 to -0.34 ± 0.16. 
Ccnd1 expression in control HC-11 cells varied from 
-0.32 ± 0.21 at 4 hours and 0.32 ± 0.12 at 16 hours. 
HC- 11 cells transfected with Sequence 2 levels of Ccnd1 
did not change between 4-hour and 16-hour time points 
(0.019 ± 0.18 and -0.019 ± 0.065). Levels of Ccnd1 
changed from a relative expression of -0.12 ± 0.29 at 
4 hours to 0.12 ± 0.14 at 16 hours in HC-11 lines carrying 
Sequence 4 shRNA. Interestingly, levels of Ccnd1 were 
elevated in lines carrying shRNA Sequence 2 relative to 
wild-type lines at both time points
Growth curves revealed that cultures transfected with 
shRNA Sequence 2 had reached almost a twofold higher 
cell density (3,423,158 cells/35mm2 ± 160,862 cells) 
compared to control HC-11 cells (1,867,020 cells/35mm2 
± 1,174,727 cells ) within 8 days (Figure 4). Cells grew 
similarly in lag phase until day 4, when they entered 
log phase of growth. Log phase doubling time between 
days 4 and 6 was 43 hours for Sequence 2, and doubling 
Figure 4. Analysis of the impact of shClock on HC-11 growth 
curves. Wild-type HC-11 (black), Sequence 2 (gray), and 
Sequence 4 (dashed) cells were plated at 100,000 cells/35mm 
dish. Duplicate wells were harvested from each line on days 
2, 4, 6, and 8, and cells were stained with Trypan blue and 
counted for live cells using a BioRad TC20 cell counter. Mean 
values of the technical and biological replicates and standard 
deviation of cell counts were graphed. The experiment was 
repeated three times. Treatment and day had a significant 
impact on growth (P < 0.05). Post hoc analysis found 
Sequence 2 growth significantly different (P < 0.05) from wild-
type and Sequence 4, but no difference between wild-type and 
Sequence 4 growth (P > 0.05). 
Figure 3. Impact of shRNA sequence on expression of Clock, Per 1, and Ccnd1 in HC-11 cells at 4-hour and 16-hour circadian time 
points. Cells were grown to confluence, cultures were synchronized by media change, and RNA was isolated from cells 4 hours and 
16 hours later. Expression of Clock, Per1, and Ccnd1 were measured in HC-11 wild-type cultures (black) and cultures transfected with 
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time for HC-11 cells was 64 hours over the same period. 
Doubling times were significantly different, with  
P = 0.040. 
DISCUSSION
Clock mRNA expression was decreased in Sequence 
2 shRNA transfected cells by ~70%, while in cultures 
carrying Sequence 4 shRNA Clock expression was 
reduced by 30%. Western blot analysis revealed CLOCK 
protein levels were significantly lower in the line carrying 
Sequence 2 as compared to nontransfected HC-11 cells 
(Figure 2). Although Clock gene expression was decreased 
in cells transfected with Sequence 4 shClock, levels of 
CLOCK protein were not different from HC-11 controls. 
Transcription and translation do not have a simple linear 
relationship (Maier, Guell, & Serrano, 2009). A difference 
in mRNA levels, but a lack of difference in protein levels, 
may be due to factors including mRNA stability, mRNA 
secondary structure, regulatory proteins, and protein 
half-lives (Maier et al., 2009). Thus, because lower levels 
of mRNA do not necessarily confirm a low amount of 
CLOCK protein, it was necessary to show that CLOCK 
protein levels were decreased in lines transfected with 
shClock. These data show that the level of CLOCK protein 
were decreased in Sequence 2 transfected cells relative to 
HC-11 cells, but Sequence 4 did not significantly impact 
CLOCK protein abundance. 
Differences in effectiveness of Sequence 2 and 
Sequence 4 shRNA in decreasing levels of CLOCK 
mRNA expression and protein abundance may be the 
result of nucleotide sequence variation of shRNA inserts 
(Rao et al., 2009). Thus, it is likely that the Sequence 
2 plasmid sequence more effectively targeted the 
Clock mRNA transcript and therefore more effectively 
prevented it from being translated into protein. 
Alternatively, off-target effects that may have led to 
variations in expression reduction may have been due to 
differences in the location and number of integrations 
of shRNA sequence into the genome, or due to an 
immunological response to the introduction of dsRNA 
(Rao et al., 2009). Together, these data support that the 
nucleotide of Sequence 2 shClock significantly reduced 
CLOCK protein abundance, while Sequence 4 had 
minimal to no effects on CLOCK protein levels. 
In addition to analyzing the gene expression of Clock¸ 
we also measured the expression of Per1 and Ccnd1. 
Previous studies in our lab showed that HC-11 cells have 
a functional clock, as the core clock genes Arntl, Per1, 
Per2, and Cry1 exhibit circadian rhythms of expression, 
with peak and trough of expression of Per1 occurring at 
4 hours and 16 hours after media change (Casey et al., 
2014). Consistent with this finding, Per1 levels exhibited 
a 3.4-fold difference in expression levels between 4-hour 
and 16-hour time points in wild-type HC-11 cultures, 
supporting a functional molecular clock. In contrast, Per1 
did not oscillate between 4-hour and 16-hour time points 
in HC-11 cultures carrying Sequence 2 shRNA levels, 
supporting that significantly decreasing CLOCK protein 
abundance effectively eliminated the function of the 
molecular clock. In cultures carrying Sequence 4, shRNA 
levels of Per1 varied by only 0.69-fold, suggesting that 
this sequence may have somewhat diminished the function 
of the molecular clock.
Levels of Ccnd1 expression oscillated between 4 hours 
and 16 hours in wild-type HC-11 cells. The molecular 
clock indirectly controls Ccnd1 expression, so rhythmicity 
of Ccnd1 was expected in wild-type cells (Fu et al., 
2005). However, Ccnd1 exhibited no significant change 
in expression between 4-hour and 16-hour time points 
in Sequence 2 transfected cells, and it was consistently 
higher in Sequence 2 transfected cells at both time points 
relative to wild-type HC-11 cultures. 
Ccnd1 encodes a cell cycle molecule, cyclin D1, which 
regulates progression through the G1/S checkpoint of the 
cell cycle. Musgrove, Lee, Buckley, and Sutherland (1994) 
showed that increasing levels of cyclin D1 in breast 
cancer cells increased the rate of cell-cycle progression. 
Further, Wood and colleagues (2008) showed that down 
regulation of Per1 and Per2 in mouse breast cancer cells 
increased Ccnd1 expression and enhanced cell growth. We 
have demonstrated in this study that decreasing CLOCK 
abundance, which resulted in loss of Per1 oscillation 
and consistently high levels of Ccnd1, increased the rate 
of cell growth in a normal mouse mammary epithelial 
cell line. In particular, Sequence 2 transfected cells had 
a faster doubling time than HC-11 cells. Together, these 
findings suggest that loss of molecular clock function 
increases Ccnd1 expression levels across the day and 
leads to enhanced cell growth. These data support that 
the mammary clock regulates growth and development 
of the gland, and they demonstrate that loss of the 
circadian clock may lead to unregulated growth. Cancer 
is characterized by increased and uncontrolled cell 
proliferation, so a better understanding of the mammary 
circadian clock’s role in this process has the potential for 
development of new preventative measures or treatments 
for breast cancer.
In future studies, we will further examine the connection 
between the gene Clock and the cell cycle. Future 
experiments will include more control cell lines, such 
as a working nontargeting scramble sequence, which 
is needed to show that any effects seen in gene or 
protein expression are not a result of the transfection 
procedure. Additionally, we hope to examine the 
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expression of other cell cycle regulatory genes believed 
to be controlled by the molecular clock, such as Wee1 
and C-myc, to determine if these genes are affected by 
shRNA targeting Clock. 
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